Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Schmidt

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Geriatric Nursing (New York, N.Y.)|December 14, 2004
Gerontologic nurse practitioner care guidelines: cellulitis in the elderly personJoan Rowe Williams, Ann Schmidt Luggen
Geriatric Nursing (New York, N.Y.)|June 24, 2005
Geriatric nurse practitioner guideline: periodontal disease in older adultsMary Alice Momeyer, Ann Schmidt Luggen
Journal of Graduate Medical Education|April 20, 2026
How Do I Decide What Data to Visualize?Caroline G Coleman, Ann Schmidt, Jonathan Schwabish
Geriatric Nursing (New York, N.Y.)|April 27, 2004
Assessment of pain in the cognitively impaired older adult in long-term carePatricia M Mezinskis, Ann W Keller, Ann Schmidt Luggen
Journal of the International AIDS Society|July 29, 2022
Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choiceHeather-Marie Ann Schmidt, Michelle Rodolph, Robin Schaefer, et al.
AIDS (London, England)|September 29, 2022
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxisAmrit Kaur Ahluwalia, Seth Inzaule, Rachel Clare Baggaley, et al.
AIDS Research and Human Retroviruses|March 6, 2004
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission modelsChe-Chung Tsai, Peter Emau, Yonghou Jiang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2003
Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaquesLoren Kinman, Scott J Brodie, Che Chung Tsai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2026
The "PrEP APPEAL" of less frequent dosing: acceptability of six-monthly long acting-injectable PrEP among gay and other men who have sex with men and transgender women in AsiaHeather-Marie Ann Schmidt, Curtis Chan, Jason Ong, et al.
The Lancet. HIV|June 21, 2025
Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxisGert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Geriatric Nursing (New York, N.Y.)|December 14, 2004
Gerontologic nurse practitioner care guidelines: cellulitis in the elderly personJoan Rowe Williams, Ann Schmidt Luggen
Geriatric Nursing (New York, N.Y.)|June 24, 2005
Geriatric nurse practitioner guideline: periodontal disease in older adultsMary Alice Momeyer, Ann Schmidt Luggen
Journal of Graduate Medical Education|April 20, 2026
How Do I Decide What Data to Visualize?Caroline G Coleman, Ann Schmidt, Jonathan Schwabish
Geriatric Nursing (New York, N.Y.)|April 27, 2004
Assessment of pain in the cognitively impaired older adult in long-term carePatricia M Mezinskis, Ann W Keller, Ann Schmidt Luggen
Journal of the International AIDS Society|July 29, 2022
Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choiceHeather-Marie Ann Schmidt, Michelle Rodolph, Robin Schaefer, et al.
AIDS (London, England)|September 29, 2022
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxisAmrit Kaur Ahluwalia, Seth Inzaule, Rachel Clare Baggaley, et al.
AIDS Research and Human Retroviruses|March 6, 2004
Cyanovirin-N inhibits AIDS virus infections in vaginal transmission modelsChe-Chung Tsai, Peter Emau, Yonghou Jiang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2003
Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaquesLoren Kinman, Scott J Brodie, Che Chung Tsai, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 24, 2026
The "PrEP APPEAL" of less frequent dosing: acceptability of six-monthly long acting-injectable PrEP among gay and other men who have sex with men and transgender women in AsiaHeather-Marie Ann Schmidt, Curtis Chan, Jason Ong, et al.
The Lancet. HIV|June 21, 2025
Lenacapavir-associated drug resistance: implications for scaling up long-acting HIV pre-exposure prophylaxisGert van Zyl, Mateo Prochazka, Heather-Marie Ann Schmidt, et al.
Pageof 3